Alpha1-adrenergic receptor blockade blocks LH secretion but not LHRH cFos activation

Wei Wei Le, Kathie A. Berghorn, M (Susan) Smith, Gloria E. Hoffman

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Long-standing pharmacological evidence supports a role of α-noradrenergic receptors in regulating LH release, yet little is known of the action of these receptors on LHRH neurons at the cellular level. We conducted a series of studies aimed at examining the effects of α-adrenergic receptor blockade on LH secretion and the cellular activation of LHRH neurons on proestrus. Our initial study used an irreversible α-receptor blocker, phenoxybenzamine (α1 > α2). A group of proestrous rats were treated with phenoxybenzamine at doses of 20 mg/kg, intraperitoneally, or 2, 10 and 20 mg/kg, intravenously, and compared with vehicle injected controls. Phenoxybenzamine administered intraperitoneally did not completely block the LH surge in all animals, whereas all intravenous doses consistently blocked the LH surge. cFos activation of LHRH neurons, on the other hand, was either unaffected or only slightly reduced by phenoxybenzamine treatment intraperitoneally. The effects of intravenous phenoxybenzamine were different, in that at all dose levels phenoxybenzamine completely blocked the LH surge and reduced by approximately half, the cFos activation in LHRH neurons (independent of dose). The effects of intravenous phenoxybenzamine could be mimicked by substitution of prazosin (an α1 antagonist, 4 mg/kg), but not idazoxan (an α2 antagonist, 1 mg/kg), administered intravenously at 11.00 h and 13.00 h on proestrus. These data provide evidence that noradrenergic systems operating through α1-receptors in the neuronal chain leading to the LH surge, while critical for the release of LHRH at the time of an LH surge, are not responsible for the cFos transcriptional changes in LHRH neurons that accompany the natural LH surge.

Original languageEnglish (US)
Pages (from-to)236-245
Number of pages10
JournalBrain Research
Volume747
Issue number2
DOIs
StatePublished - Feb 7 1997
Externally publishedYes

Fingerprint

Phenoxybenzamine
Gonadotropin-Releasing Hormone
Adrenergic Receptors
Neurons
Proestrus
Idazoxan
LHRH Receptors
Prazosin
Pharmacology

Keywords

  • estrous cycle
  • idazoxan
  • immediate early genes
  • immunocytochemistry
  • prazosin
  • preoptic area
  • proestrus
  • rat

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology
  • Developmental Biology
  • Molecular Biology

Cite this

Alpha1-adrenergic receptor blockade blocks LH secretion but not LHRH cFos activation. / Le, Wei Wei; Berghorn, Kathie A.; Smith, M (Susan); Hoffman, Gloria E.

In: Brain Research, Vol. 747, No. 2, 07.02.1997, p. 236-245.

Research output: Contribution to journalArticle

Le, Wei Wei ; Berghorn, Kathie A. ; Smith, M (Susan) ; Hoffman, Gloria E. / Alpha1-adrenergic receptor blockade blocks LH secretion but not LHRH cFos activation. In: Brain Research. 1997 ; Vol. 747, No. 2. pp. 236-245.
@article{e851533d4eb2422480d3dcd25f3a43a3,
title = "Alpha1-adrenergic receptor blockade blocks LH secretion but not LHRH cFos activation",
abstract = "Long-standing pharmacological evidence supports a role of α-noradrenergic receptors in regulating LH release, yet little is known of the action of these receptors on LHRH neurons at the cellular level. We conducted a series of studies aimed at examining the effects of α-adrenergic receptor blockade on LH secretion and the cellular activation of LHRH neurons on proestrus. Our initial study used an irreversible α-receptor blocker, phenoxybenzamine (α1 > α2). A group of proestrous rats were treated with phenoxybenzamine at doses of 20 mg/kg, intraperitoneally, or 2, 10 and 20 mg/kg, intravenously, and compared with vehicle injected controls. Phenoxybenzamine administered intraperitoneally did not completely block the LH surge in all animals, whereas all intravenous doses consistently blocked the LH surge. cFos activation of LHRH neurons, on the other hand, was either unaffected or only slightly reduced by phenoxybenzamine treatment intraperitoneally. The effects of intravenous phenoxybenzamine were different, in that at all dose levels phenoxybenzamine completely blocked the LH surge and reduced by approximately half, the cFos activation in LHRH neurons (independent of dose). The effects of intravenous phenoxybenzamine could be mimicked by substitution of prazosin (an α1 antagonist, 4 mg/kg), but not idazoxan (an α2 antagonist, 1 mg/kg), administered intravenously at 11.00 h and 13.00 h on proestrus. These data provide evidence that noradrenergic systems operating through α1-receptors in the neuronal chain leading to the LH surge, while critical for the release of LHRH at the time of an LH surge, are not responsible for the cFos transcriptional changes in LHRH neurons that accompany the natural LH surge.",
keywords = "estrous cycle, idazoxan, immediate early genes, immunocytochemistry, prazosin, preoptic area, proestrus, rat",
author = "Le, {Wei Wei} and Berghorn, {Kathie A.} and Smith, {M (Susan)} and Hoffman, {Gloria E.}",
year = "1997",
month = "2",
day = "7",
doi = "10.1016/S0006-8993(96)01269-3",
language = "English (US)",
volume = "747",
pages = "236--245",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Alpha1-adrenergic receptor blockade blocks LH secretion but not LHRH cFos activation

AU - Le, Wei Wei

AU - Berghorn, Kathie A.

AU - Smith, M (Susan)

AU - Hoffman, Gloria E.

PY - 1997/2/7

Y1 - 1997/2/7

N2 - Long-standing pharmacological evidence supports a role of α-noradrenergic receptors in regulating LH release, yet little is known of the action of these receptors on LHRH neurons at the cellular level. We conducted a series of studies aimed at examining the effects of α-adrenergic receptor blockade on LH secretion and the cellular activation of LHRH neurons on proestrus. Our initial study used an irreversible α-receptor blocker, phenoxybenzamine (α1 > α2). A group of proestrous rats were treated with phenoxybenzamine at doses of 20 mg/kg, intraperitoneally, or 2, 10 and 20 mg/kg, intravenously, and compared with vehicle injected controls. Phenoxybenzamine administered intraperitoneally did not completely block the LH surge in all animals, whereas all intravenous doses consistently blocked the LH surge. cFos activation of LHRH neurons, on the other hand, was either unaffected or only slightly reduced by phenoxybenzamine treatment intraperitoneally. The effects of intravenous phenoxybenzamine were different, in that at all dose levels phenoxybenzamine completely blocked the LH surge and reduced by approximately half, the cFos activation in LHRH neurons (independent of dose). The effects of intravenous phenoxybenzamine could be mimicked by substitution of prazosin (an α1 antagonist, 4 mg/kg), but not idazoxan (an α2 antagonist, 1 mg/kg), administered intravenously at 11.00 h and 13.00 h on proestrus. These data provide evidence that noradrenergic systems operating through α1-receptors in the neuronal chain leading to the LH surge, while critical for the release of LHRH at the time of an LH surge, are not responsible for the cFos transcriptional changes in LHRH neurons that accompany the natural LH surge.

AB - Long-standing pharmacological evidence supports a role of α-noradrenergic receptors in regulating LH release, yet little is known of the action of these receptors on LHRH neurons at the cellular level. We conducted a series of studies aimed at examining the effects of α-adrenergic receptor blockade on LH secretion and the cellular activation of LHRH neurons on proestrus. Our initial study used an irreversible α-receptor blocker, phenoxybenzamine (α1 > α2). A group of proestrous rats were treated with phenoxybenzamine at doses of 20 mg/kg, intraperitoneally, or 2, 10 and 20 mg/kg, intravenously, and compared with vehicle injected controls. Phenoxybenzamine administered intraperitoneally did not completely block the LH surge in all animals, whereas all intravenous doses consistently blocked the LH surge. cFos activation of LHRH neurons, on the other hand, was either unaffected or only slightly reduced by phenoxybenzamine treatment intraperitoneally. The effects of intravenous phenoxybenzamine were different, in that at all dose levels phenoxybenzamine completely blocked the LH surge and reduced by approximately half, the cFos activation in LHRH neurons (independent of dose). The effects of intravenous phenoxybenzamine could be mimicked by substitution of prazosin (an α1 antagonist, 4 mg/kg), but not idazoxan (an α2 antagonist, 1 mg/kg), administered intravenously at 11.00 h and 13.00 h on proestrus. These data provide evidence that noradrenergic systems operating through α1-receptors in the neuronal chain leading to the LH surge, while critical for the release of LHRH at the time of an LH surge, are not responsible for the cFos transcriptional changes in LHRH neurons that accompany the natural LH surge.

KW - estrous cycle

KW - idazoxan

KW - immediate early genes

KW - immunocytochemistry

KW - prazosin

KW - preoptic area

KW - proestrus

KW - rat

UR - http://www.scopus.com/inward/record.url?scp=0030614358&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030614358&partnerID=8YFLogxK

U2 - 10.1016/S0006-8993(96)01269-3

DO - 10.1016/S0006-8993(96)01269-3

M3 - Article

C2 - 9045998

AN - SCOPUS:0030614358

VL - 747

SP - 236

EP - 245

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 2

ER -